"Allina Health Cancer Institute – Minneapolis, formerly known as Virginia Piper Cancer Institute - Abbott Northwestern Hospital provides expert cancer care."

During the past decade, Virginia Piper Cancer Institute at Abbott - Northwestern Hospital conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 157 clinical trials were completed, i.e. on average, 413.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 36 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Piper Cancer Institute at Abbott - Northwestern Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 86 trials, followed by "Eastern Cooperative Oncology Group" with 34 trials sponsored, "National Cancer Institute (NCI)" with 31 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored and "Radiation Therapy Oncology Group" with 20 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Piper Cancer Institute at Abbott - Northwestern Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 177 trials as a collaborator, "Cancer and Leukemia Group B" with 18 trials as a collaborator, "NCIC Clinical Trials Group" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 15 trials as a collaborator and "NRG Oncology" with 13 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Piper Cancer Institute at Abbott - Northwestern Hospital" are "Breast Cancer" (43 trials), "Lung Cancer" (25 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (16 trials), "Lymphoma" (14 trials) and "Leukemia" (12 trials). Many other conditions were trialed in "Virginia Piper Cancer Institute at Abbott - Northwestern Hospital" in a lesser frequency.

Most popular intervention types in "Virginia Piper Cancer Institute at Abbott - Northwestern Hospital" are "Drug" (231 trials), "Biological" (80 trials), "Other" (70 trials), "Radiation" (49 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (35 trials), "radiation therapy" (22 trials), "bevacizumab" (21 trials), "carboplatin" (18 trials) and "Laboratory Biomarker Analysis" (17 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Piper Cancer Institute at Abbott - Northwestern Hospital" are 223 trials for "All" genders, 34 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Piper Cancer Institute at Abbott - Northwestern Hospital". undefined are not yet recruiting, 4 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 197 completed trials in Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, undefined suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, 26 "Phase 1" clinical trials were conducted, 128 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".